Effect of Erythropoietin (EPO) in Kidney After Cardiac Surgery

• Status: Completed
• Trial end date: 2009-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether erythropoietin is effective in preventing acute kidney dysfunction after coronary artery bypass grafting surgery.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Seoul National University Bundang Hospital
• Treatments: Epoetin Alfa

Criteria

Inclusion Criteria:

• Patients scheduled for elective CABG over age 18

Exclusion Criteria:

• Under age 18

• Emergent CABG

• Prior exposure to nephrotoxic drug

• Dialysis patients

• Uncontrolled hypertension